The 6th mRNA Analytical Development and Quality Control Summit focuses on advancing assay development, analytical methods, and quality control to expedite regulatory compliance and approval processes for mRNA therapeutics and vaccines.
Key Topics
Maximizing Resolution & Sensitivity in Purity & Integrity Assays Through Advanced Analytical Techniques & GMP-Compliant Methodologies
Advancing Precise Potency Assays to Optimize Product Quality, Efficacy & Regulatory Adherence for Efficient & Expeditious Approval
Exploring Novel Advances in the Analytical Toolbox to Permit the Efficient Release & Commercial Approval of mRNA Vaccines & Therapeutics
Bridging Analytical, Quality & Assay Development Priorities to Meet GMP Guidelines for Faster mRNA Drug Approvals
Bolstering the Industries-Leading Delivery Vehicle: Optimizing LNP Formulation & Characterization to Enhance Delivery Efficacy & mRNA Payload
Pioneering Characterization Methods to Profile the Identity of mRNA Medicines for Faster mRNA Drug Approvals
Examining Alternative & Emerging Delivery Vehicles to Fuel the Clinical Progression of Novel mRNA Loaded Nanomedicines with Improved Safety & Efficacy
